Ameditech Inc recalls Premier Clia Waived 12 panel Tilt Cup, Item No. C12APC These Drugs of Abuse Tests are one-step immunoassays for the q

Recalled November 25, 2015 · FDA recall Z-0314-2016 · Ameditech

Hazard

Ameditech is recalling drug abuse tests because they have shown reduced reactivity. · FDA Class II

Units

384 units

Sold at

Worldwide Distribution - US (nationwide) and Internationally to Australia.

Description

Ameditech is recalling drug abuse tests because they have shown reduced reactivity.

Product

Premier Clia Waived 12 panel Tilt Cup, Item No. C12APC These Drugs of Abuse Tests are one-step immunoassays for the qualitative detection of multiple drugs and drug metabolites in human urine. The configurations of these Drugs of Abuse Tests consist of a combination of drug strips, including Benzodiazepine (BZO). They are used to obtain a visual, qualitative result and are intended for professional and point of care use. ¿¿¿

Manufacturer(s)

Ameditech Inc

Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →